Appearing as a promising development in the battle against obesity, this medication is capturing considerable interest . It combines properties of two recognized GLP-1 binding agonists, liraglutide, with an additional glucose-dependent hormonal component. Early patient findings have shown significant weight reduction in people with obesity , poten